Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Add filters

Document Type
Year range
Lung India ; 39(SUPPL 1):S146-S147, 2022.
Article in English | EMBASE | ID: covidwho-1857842


Background: Tuberculosis(TB) is one among the various respiratory pathologies affecting post-covid patients. We intend to describe clinico-radiological characteristics of tuberculosis in post-covid patients. Methods: Retrospective descriptive study, conducted at SDS TRC and RGICD, Bengaluru from May 2020 to November 2021 with inclusion criteria of Tuberculosis with history of COVID in last 6 months. Clinicoradiological characteristics of them were retrieved from medical records section. Results: 13 patients were included in our study. Male predominance (69%), with mean age of 50.7years noted. Patient with co-morbidity were 61.53%, majority were diabetics. 46% severe, 15%moderate covid cases received corticosteroids during covid illness and 38% were mild who didn't receive corticosteroids. Mean duration of TB diagnosis after covid was 2 months. 5 patients were diagnosed as pulmonary tuberculosis with cough, fever, weight loss as presentation, 6 presented with air-leak in which 4 had hydropneumothorax, 2 had pneumothorax with dyspnea as presentation and 2 had pleural effusion. 69% of chest radiograph revealed cavity. Rest showed nodules, consolidation. Bandim-TB score was assigned. 4 were mild and rest 11 were of moderate to severe category. AFB Sputum smear / CBNAAT-positive in 85% cases. Among 2 pleural effusions, pleural fluid CBNAAT was positive in 1 and in other biochemical analysis was suggestive of tuberculosis. 15% were Rifampicin resistant TB. All except 1 were newly diagnosed tuberculosis. 2 patients succumbed to the disease and rest were discharged on appropriate anti-tubercular regimen. Conclusion: Post-covid patients when presents with persistent or worsening respiratory symptoms, tuberculosis should be excluded especially in endemic countries like India.

Lung India ; 39(SUPPL 1):S143-S144, 2022.
Article in English | EMBASE | ID: covidwho-1857825


Background: Air - leak syndrome is one of the dreaded complication in COVID -19 viral pneumonia. It has been described in severe cases during acute COVID -19 Infection. Spontaneous pneumothorax after mild COVID-19 disease has been rarely reported. Methods: A retrospective descriptive study was conducted in SDS TRC AND RGICD, Bangalore. All patients presenting to our hospital from May 2021 to October 2021 with air -leak syndrome with a prior history of COVID -19 infection were included. Details obtained from the medical records included the demographics, radiology, laboratory investigations and outcome. Results: 24 patients presented with air- leak syndrome. Median age was 54 years with male predominance (84%). 33% had severe COVID disease, 29% had moderate and 37% were mild COVID cases. Median duration of presentation with air -leak syndrome from covid-19 infection was 29 days (Range- 8-90). 58% had Hydro-pneumothorax and 41% had pneumothorax. Pleural fluid analysis was suggestive of para-pneumonic effusion in 11cases while three had tubercular hydro-pneumothorax. Mean duration of ICD in-situ was 24days . Chest radiography showed consolidation in 21 patients and 3 patients had no consolidation, pneumatocele was observed in 2 patients . one patient developed BPF, 3 patients succumbed and the rest were discharged. Conclusion: Air-leak syndrome is a life threatening complication of COVID-19 infection which can manifest even after a mild disease and with out NIV use . Multiple factors lead to development of air -leak syndrome. Prompt recognition of the same is crucial to avoid mortality.